Eligibility for Adjuvant Cyclin-Dependent Kinase 4/6 Inhibitors in Endocrine Receptor-Positive and HER2-Negative Early Breast Cancer by Age and Type of Surgery.
Houvenaeghel G, Classe JM, Chauvet MP, Colombo PE, Jouve E, Reyal F, Daraï E, Rouzier R, Faure-Virelizier C, Gimbergues P, Coutant C, Mazouni C, Azuar AS, Martino M, Bouteille C, Cohen M, de Nonneville A.
Houvenaeghel G, et al. Among authors: cohen m.
Cancers (Basel). 2024 Sep 27;16(19):3317. doi: 10.3390/cancers16193317.
Cancers (Basel). 2024.
PMID: 39409937